Cognition Therapeutics Files 8-K

Ticker: CGTX · Form: 8-K · Filed: Jun 3, 2025 · CIK: 1455365

Cognition Therapeutics INC 8-K Filing Summary
FieldDetail
CompanyCognition Therapeutics INC (CGTX)
Form Type8-K
Filed DateJun 3, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-filing, 8-K, regulatory-update

TL;DR

Cognition Therapeutics filed an 8-K on June 3rd, updating its corporate info. Nothing major, just housekeeping.

AI Summary

Cognition Therapeutics, Inc. filed an 8-K on June 3, 2025, reporting other events and financial statements. The filing details the company's principal executive offices located at 2500 Westchester Ave, Purchase, NY, 10577, and its telephone number as (412) 481-2210. The company is incorporated in Delaware and operates in the Biological Products sector.

Why It Matters

This 8-K filing provides updated corporate information and signals ongoing regulatory and financial reporting activities for Cognition Therapeutics.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for corporate information updates and does not appear to contain material non-public information that would immediately impact stock price.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

This 8-K filing serves as a current report for Cognition Therapeutics, Inc., detailing other events and financial statements, and updating corporate information.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on June 3, 2025.

Where are Cognition Therapeutics, Inc.'s principal executive offices located?

The principal executive offices of Cognition Therapeutics, Inc. are located at 2500 Westchester Ave, Purchase, NY, 10577.

What is the telephone number for Cognition Therapeutics, Inc.?

The telephone number for Cognition Therapeutics, Inc., including area code, is (412) 481-2210.

In which U.S. state is Cognition Therapeutics, Inc. incorporated?

Cognition Therapeutics, Inc. is incorporated in Delaware.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding COGNITION THERAPEUTICS INC (CGTX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing